The trypanocidal effect of NO-releasing agents is not due to inhibition of the major cysteine proteinase in Trypanosoma brucei

Parasitology Research

Volumn 105, Issue 5, 2009, Pages 1333-1338

  Steverding, Dietmar ^a   Wang, Xia ^a   Sexton, Darren W ^a  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 ETHYL 2 HYDROXYIMINO 5 NITRO 3 HEXENAMIDE; CYSTEINE PROTEINASE; LINSIDOMINE; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE DONOR; S NITROSOGLUTATHIONE;

ARTICLE; CATALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG PURIFICATION; ENZYME ACTIVITY; ENZYME INHIBITION; GROWTH INHIBITION; IN VITRO STUDY; LYSOSOME; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; TRYPANOSOMA BRUCEI;

ANIMALS; CELL SURVIVAL; CYSTEINE ENDOPEPTIDASES; LYSOSOMES; NITRIC OXIDE; TRYPANOCIDAL AGENTS; TRYPANOSOMA BRUCEI BRUCEI;

LEISHMANIA INFANTUM; PLASMODIUM FALCIPARUM; PROTOZOA; TRYPANOSOMA BRUCEI; TRYPANOSOMA CRUZI;

EID: 70349604793     PISSN: 09320113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00436-009-1559-x     Document Type: Article

References (28)

1. P Ascenzi A Bocedi M Gentile P Visca L Gradoni 2004 Inactivation of parasite cysteine proteinases by the NO-donor 4-(phenylsulfonyl)-3-((2- (dimethylamino)ethyl)thio)-furoxan oxalate Biochim Biophys Acta 1703 69 77 15588704 1:CAS:528:DC%2BD2cXhtVaqtr3M
2. T Baltz D Baltz C Giroud J Crockett 1985 Cultivation in a semi-defined medium of animal infective forms of Trypanosoma brucei, T. equiperdum, T. evansi, T. rhodesiense and T. gambiense EMBO J 4 1273 1277 4006919 1:CAS:528:DyaL2MXlslGhtb8%3D
3. AJ Barrett H Kirschke 1981 Cathepsin B, cathepsin H, and cathepsin L Methods Enzymol 80 535 561 7043200 10.1016/S0076-6879(81)80043-2 1:CAS:528:DyaL38XitFejsLw%3D
4. A Bocedi L Gradoni E Menegatti P Ascenzi 2004 Kinetics of parasite cysteine proteinase inactivation by NO-donors Biochem Biophys Res Commun 315 710 718 14975759 10.1016/j.bbrc.2004.01.113 1:CAS:528:DC%2BD2cXht1yit70%3D (Pubitemid 38229401)
5. SC Bourguignon CR Alves S Giovanni-De-Simone 1997 Detrimental effect of nitric oxide on Trypanosoma cruzi and Leishmania major like cells Acta Trop 66 109 118 9227803 10.1016/S0001-706X(97)00033-8 1:CAS:528:DyaK2sXktlOhu70%3D (Pubitemid 27285950)
6. CR Caffrey E Hansell KD Lucas LS Brinen A Alvarez Hernandez J Cheng SL Gwaltney 2nd WR Roush YD Stierhof M Bogyo D Steverding JH McKerrow 2001 Active site mapping, biochemical properties and subcellular localization of rhodesain, the major cysteine protease of Trypanosoma brucei rhodesiense Mol Biochem Parasitol 118 61 73 11704274 10.1016/S0166-6851(01)00368-1 1:CAS:528: DC%2BD3MXotFSqsrk%3D (Pubitemid 33043821)
7. IA Clark KA Rockett 1996 Nitric oxide and parasitic disease Adv Parasitol 37 1 56 8881597 10.1016/S0065-308X(08)60218-3 1:STN:280:DyaK2s%2FjsF2nuw%3D%3D
8. AH Fairlamb 2003 Chemotherapy of human African trypanosomiasis: current and future prospects Trends Parasitol 19 488 494 14580959 10.1016/j.pt.2003.09. 002 1:CAS:528:DC%2BD3sXosVyisL8%3D (Pubitemid 37329657)
9. B Fast K Kremp M Boshart D Steverding 1999 Iron-dependent regulation of transferrin receptor expression in Trypanosoma brucei Biochem J 342 691 696 10477281 10.1042/0264-6021:3420691 1:CAS:528:DyaK1MXmsVygsL4%3D (Pubitemid 29452655)
10. DJ Grab CW Wells MK Shaw P Webster DCW Russo 1992 Endocytosed transferrin in African trypanosomes is delivered to lysosomes and may not be recycled Eur J Cell Biol 59 398 404 1493805 1:CAS:528:DyaK3sXkt1Glurs%3D
11. H Hirumi K Hirumi JJ Doyle GAM Cross 1980 In vitro cloning of animal-infective bloodstream forms of Trypanosoma brucei Parasitology 80 371 382 6154276 10.1017/S0031182000000822 1:STN:280:DyaL3c7ms1CltA%3D%3D
12. 50 in studies of drug resistance of malaria parasites Acta Trop 55 257 261 8147282 10.1016/0001-706X(93)90083-N 1:STN:280:DyaK2c7pslSktQ%3D%3D
13. PM Kristjanson BM Swallow GJ Rowlands RL Kruska PN de Leeuw 1999 Measuring the costs of African animal trypanosomosis, the potential benefits of control and returns to research Agr Sys 59 79 98 10.1016/S0308-521X(98)00086-9 (Pubitemid 29107430)
14. E Matovu T Seebeck JCK Enyaru R Kaminsky 2001 Drug resistance in Trypanosoma brucei spp., the causative agents of sleeping sickness in man and nagana in cattle Microbes Infect 3 763 770 11489425 10.1016/S1286-4579(01)01432- 0 1:CAS:528:DC%2BD3MXls1egsrw%3D (Pubitemid 32727386)
15. NJ Nkemngu R Grande E Hansell JH McKerrow CR Caffrey D Steverding 2003 Improved trypanocidal activities of cathepsin L inhibitors Int J Antimicrob Agents 22 155 159 10.1016/S0924-8579(03)00096-7 (Pubitemid 36970175)
16. P Petray E Castaños-Velez A Grinstein A Orn ME Rottenberg 1995 Role of nitric oxide in resistance and histopathology during experimental infection with Trypanosoma cruzi Immunol Lett 47 121 126 8537088 10.1016/0165-2478(95) 00083-H 1:CAS:528:DyaK2MXotVarsb8%3D
17. KA Rockett MM Awburn WB Cowden IA Clark 1991 Killing of Plasmodium falciparum in vitro by nitric oxide derivatives Infect Immun 59 3280 3283 1879941 1:CAS:528:DyaK3MXmslOrur0%3D
18. Ross CA, Sutherland DV (1997) Drug resistance in trypamosomatids. In: Hide G, Mottram JC, Coombs GH, Holmes PH (eds) Trypanosomiasis and leishmaniasis: biology and control. CAB International, Wallingford, pp 259-269
19. L Salvati M Mattu M Colasanti A Scalone G Venturini L Gradoni P Ascenzi 2001 NO donors inhibit Leishmania infantum cysteine proteinase activity Biochim Biophys Acta 1545 357 366 11342060 1:CAS:528:DC%2BD3MXpsFKqsA%3D%3D
20. 2 Exp Parasitol 91 327 333 10092476 10.1006/expr.1998.4381 1:CAS:528:DyaK1MXhvF2jur0%3D (Pubitemid 29372437)
21. D Steverding 2008 The history of African trypanosomiasis Parasit Vectors 1 3 18275594 10.1186/1756-3305-1-3
22. D Steverding YD Stierhof H Fuchs R Tauber P Overath 1995 Transferrin-binding protein complex is the receptor for transferrin uptake in Trypanosoma brucei J Cell Biol 131 1173 1182 8522581 10.1083/jcb.131.5.1173 1:CAS:528:DyaK2MXpvVWjs7o%3D
23. D Steverding CR Caffrey M Sajid 2006 Cysteine proteinase inhibitors as therapy for parasitic diseases: advances in inhibitor design Mini Rev Med Chem 6 1025 1032 17018001 10.2174/138955706778195207 1:CAS:528:DC%2BD28Xos1Knsbo%3D (Pubitemid 44383188)
24. G Venturini M Colasanti L Salvati L Gradoni P Ascenzi 2000 Nitric oxide inhibits falcipain, the Plasmodium falciparum trophozoite cysteine protease Biochem Biophys Res Commun 267 190 193 10623597 10.1006/bbrc.1999.1922 1:CAS:528:DC%2BD3cXht1GmsQ%3D%3D (Pubitemid 30072529)
25. G Venturini L Salvati M Muolo M Colasanti L Gradoni P Ascenzi 2000 Nitric oxide inhibits cruzipain, the major papain-like cysteine proteinase from Trypanosoma cruzi Biochem Biophys Res Commun 270 437 441 10753643 10.1006/bbrc.2000.2447 1:CAS:528:DC%2BD3cXit1CqtL0%3D (Pubitemid 30446854)
26. GN Vespa FQ Cunha JS Silva 1994 Nitric oxide is involved in control of Trypanosoma cruzi-induced parasitemia and directly kills the parasites in vitro Infect Immun 62 5177 5182 7523307 1:CAS:528:DyaK2cXmslOrtLk%3D
27. P Vincendeau S Daulouède B Veyret ML Darde B Bouteille JL Lemesre 1992 Nitric oxide-mediated cytostatic activity on Tyrpanosoma brucei gambiense and Trypanosoma brucei brucei Exp Parasitol 75 353 360 1426137 10.1016/0014-4894(92)90220-5 1:CAS:528:DyaK3sXhtVSgsro%3D
28. WHO (2006) African trypanosomiasis (sleeping sickness). World Health Organ Fact Sheet 259 [ http://www.who.int/mediacentre/factsheets/fs259/en/ ]